- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 12, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A health care news roundup from JD Supra mentioned a study published in the December 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “Financial Impact of Telehealth: Rural Chief Financial Officer Perspectives,” found that chief financial officers in rural hospitals felt that although telehealth had some financial advantages, their hospitals’ financial situation was not improved by telehealth.
A roundup from HME Business referenced a video interview published on AJMC.com, the website of AJMC. The interview, “NHIA’s Connie Sullivan Discusses the Benefits and patient Satisfaction of Home Infusion,” featured Connie Sullivan, president and CEO of the National Home Infusion Association, discussing the benefits of at-home infusion in terms of both effectiveness and satisfaction for patients.
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
